Nvidia Corp has launched what it claims is the fastest U.K. supercomputer for outside researchers, which includes scientists as well as commercial companies such as AstraZeneca and GlaxoSmithKline.
Nvidia has spent about $100 million on its Cambridge-1 system, which uses artificial intelligence to solve problems in health research.
In the case of AstraZeneca, for example, the system learns about 1 billion chemical compounds represented by character groups that can be assembled into sentence structures.
Cambridge-1 is aimed at researchers who already use smaller Nvidia-based systems for research.
Nvidia said it is offering the system for free and it will use what it learns from operating the system to improve its future healthcare products.
Nvidia is taking steps to show a commitment to the U.K. as it works to complete its $40 billion takeover of ARM Ltd from Japan’s SoftBank Group Corp.
The U.K. antitrust authorities are investigating the takeover, which would transfer ownership of one of the U.K.’s technological jewels from one foreign company to another.
In connection with the deal, Nvidia has said that it also plans to build a supercomputing center in the U.K. using ARM-designed chips.
For more information, read the orignal story in Reuters.